Adipose tissue measurement in clinical research for obesity, type 2 diabetes and NAFLD/NASH

Article Authors: Adrian Vilalta, Julio A. Gutiérrez, SuZanne Chaves, Moisés Hernández, Silvia Urbina, Marcus Hompesch

About This Article

Excess body fat is linked to higher risks for metabolic syndrome, type 2 diabetes mellitus (T2DM), and cardiovascular disease (CV), among other health conditions. However, it is not only the level but also the distribution of body fat that contributes to increased disease risks. For example, an increased level of abdominal fat, or visceral adipose tissue (VAT), is associated with a higher risk of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).

Adipose tissue measurement in clinical research for obesity, type 2 diabetes and NAFLD/NASH thumbnail